Extended Collaboration and License Agreement Sample Contracts

EXTENDED COLLABORATION AND LICENSE AGREEMENT
Extended Collaboration and License Agreement • September 27th, 2007 • Athersys, Inc / New • Pharmaceutical preparations • New York

This Extended Collaboration and License Agreement (the “Agreement”) is made and entered into as of January 1, 2006 (the “Effective Date”), by and between Athersys, Inc., a Delaware corporation having its principal offices at 3201 Carnegie Avenue, Cleveland, Ohio 44115 (“Athersys”), and Bristol-Myers Squibb Company, a Delaware corporation having offices at Route 206 and Province Line Road, Princeton, New Jersey 08543 (“BMS”). Athersys and BMS may be referred to herein individually as a “Party” and collectively as the “Parties.”

AutoNDA by SimpleDocs
AMENDMENT No. 3 TO EXTENDED COLLABORATION AND LICENSE AGREEMENT
Extended Collaboration and License Agreement • May 14th, 2012 • Athersys, Inc / New • Pharmaceutical preparations

THIS AMENDMENT NO. 3 (this “Amendment No. 3”), dated as of January 31, 2012 (the “Effective Date”), by and between ABT Holding Company, formerly operating as “Athersys, Inc.” prior to a name change, a Delaware corporation having its principal offices at 3201 Carnegie Avenue, Cleveland, Ohio 44115 (“Athersys”), and Bristol-Myers Squibb Company, a Delaware corporation having offices at Route 206 and Province Line Road, Princeton, New Jersey 08543 (“BMS”). Athersys and BMS may be referred to herein individually as a “Party” and collectively as the “Parties.”

Re: Amendment to the Extended Collaboration and License Agreement between Athersys, Inc. and Bristol-Myers Squibb Company effective January 1, 2006.
Extended Collaboration and License Agreement • April 9th, 2009 • Athersys, Inc / New • Pharmaceutical preparations

This letter agreement (this “Letter Amendment”), effective as of the date set forth above, by ABT Holding Company (“Athersys”), formerly operating as “Athersys, Inc.” prior to a name change related to its 2007 reverse merger with a wholly-owned subsidiary of a public shell company (subsequently renamed Athersys, Inc.), and Bristol-Myers Squibb Company (“BMS”), is intended to set forth the Parties’ mutual understandings with respect to, and hereby amends, that certain Extended Collaboration and License Agreement between the Parties effective January 1, 2006 (the “Extended Agreement”), as set forth herein.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!